ArticleJournal of arrhythmia2026
Kuwait Atrial Fibrillation Management Analysis-Insights From a Tertiary Center in Kuwait.
Article in Journal of arrhythmia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Real-world data on atrial fibrillation (AF) contemporary management from the Gulf region are scarce and nonexistent from Kuwait. Despite recent guideline updates favoring early rhythm control, clinical characteristics, treatment strategies, and outcomes remain poorly characterized in this region. This study aimed to evaluate AF management patterns at a tertiary center in Kuwait, focusing on rhythm vs. rate control strategies and direct oral anticoagulant (DOAC) prescribing practices. Methods: An observational study on adult patients diagnosed with AF at Al Dabbous Cardiac Center between 2013 to 2022 was conducted. Demographic data, relevant clinical characteristics, and investigations were extracted. The primary outcome was the prevalence and predictors of rhythm control. Secondary outcomes included all-cause and cardiovascular-related hospitalizations. The appropriateness of DOAC dose-reduction was assessed based on guideline-based criteria. Results: Of 558 records screened, 457 patients with non-valvular AF were included. Rhythm control was pursued in 28.9% of cases, most commonly via direct current cardioversion (47.3%). Patients selected for rhythm control were more likely to be younger (mean age 64 vs. 70 years, Conclusion: Rhythm control was underutilized in our study population, falling short of international benchmarks and guideline recommendations. Disparities in rhythm control utilization based on sex and referral patterns were observed. Additionally, among patients on dose-reduced DOACs, a significant proportion of them were underdosed. These findings highlight the need to enhance awareness of evidence-based AF management and to promote adherence to guideline-directed therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.